UK Markets close in 55 mins

Inhibikase Therapeutics, Inc. (IKT)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
0.6000+0.0075 (+1.27%)
As of 10:17AM EST. Market open.
Currency in USD
Earnings estimateCurrent qtr. (Sep 2022)Next qtr. (Dec 2022)Current year (2022)Next year (2023)
No. of analysts1111
Avg. Estimate-0.18-0.19-0.73-0.69
Low estimate-0.18-0.19-0.73-0.69
High estimate-0.18-0.19-0.73-0.69
Year ago EPS-0.18-0.2-0.81-0.73
Revenue estimateCurrent qtr. (Sep 2022)Next qtr. (Dec 2022)Current year (2022)Next year (2023)
No. of analysts1111
Avg. Estimate200k200k500k100k
Low estimate200k200k500k100k
High estimate200k200k500k100k
Year ago sales300k2k3.1M500k
Sales growth (year/est)-33.30%9,900.00%-83.90%-80.00%
Earnings history29/09/202130/12/202130/03/202229/06/2022
Est. EPS-0.14-0.17-0.17-0.19
Actual EPS-0.18-0.2-0.18-0.18
Difference-0.04-0.03-0.010.01
Surprise %-28.60%-17.60%-5.90%5.30%
EPS trendCurrent qtr. (Sep 2022)Next qtr. (Dec 2022)Current year (2022)Next year (2023)
Current estimate-0.18-0.19-0.73-0.69
7 days ago-0.18-0.19-0.73-0.69
30 days ago-0.18-0.19-0.73-0.69
60 days ago-0.18-0.19-0.73-0.69
90 days ago-0.19-0.16-0.71-0.55
EPS revisionsCurrent qtr. (Sep 2022)Next qtr. (Dec 2022)Current year (2022)Next year (2023)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/AN/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesIKTIndustrySector(s)S&P 500
Current qtr.N/AN/AN/AN/A
Next qtr.5.00%N/AN/AN/A
Current year9.90%N/AN/AN/A
Next year5.50%N/AN/AN/A
Next 5 years (per annum)N/AN/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A